| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 59651-271-01 | 59651-271 | HUMAN PRESCRIPTION DRUG | Prazosin Hydrochloride | Prazosin Hydrochloride | CAPSULE | ORAL | 20230331 | N/A | ANDA | ANDA213052 | Aurobindo Pharma Limited | PRAZOSIN HYDROCHLORIDE | 1 mg/1 | 100 CAPSULE in 1 BOTTLE (59651-271-01) |
| 59651-271-99 | 59651-271 | HUMAN PRESCRIPTION DRUG | Prazosin Hydrochloride | Prazosin Hydrochloride | CAPSULE | ORAL | 20230331 | N/A | ANDA | ANDA213052 | Aurobindo Pharma Limited | PRAZOSIN HYDROCHLORIDE | 1 mg/1 | 1000 CAPSULE in 1 BOTTLE (59651-271-99) |
| 59651-272-01 | 59651-272 | HUMAN PRESCRIPTION DRUG | Prazosin Hydrochloride | Prazosin Hydrochloride | CAPSULE | ORAL | 20230331 | N/A | ANDA | ANDA213052 | Aurobindo Pharma Limited | PRAZOSIN HYDROCHLORIDE | 2 mg/1 | 100 CAPSULE in 1 BOTTLE (59651-272-01) |
| 59651-272-99 | 59651-272 | HUMAN PRESCRIPTION DRUG | Prazosin Hydrochloride | Prazosin Hydrochloride | CAPSULE | ORAL | 20230331 | N/A | ANDA | ANDA213052 | Aurobindo Pharma Limited | PRAZOSIN HYDROCHLORIDE | 2 mg/1 | 1000 CAPSULE in 1 BOTTLE (59651-272-99) |
| 59651-273-01 | 59651-273 | HUMAN PRESCRIPTION DRUG | Prazosin Hydrochloride | Prazosin Hydrochloride | CAPSULE | ORAL | 20230331 | N/A | ANDA | ANDA213052 | Aurobindo Pharma Limited | PRAZOSIN HYDROCHLORIDE | 5 mg/1 | 100 CAPSULE in 1 BOTTLE (59651-273-01) |
| 59651-273-25 | 59651-273 | HUMAN PRESCRIPTION DRUG | Prazosin Hydrochloride | Prazosin Hydrochloride | CAPSULE | ORAL | 20230331 | N/A | ANDA | ANDA213052 | Aurobindo Pharma Limited | PRAZOSIN HYDROCHLORIDE | 5 mg/1 | 250 CAPSULE in 1 BOTTLE (59651-273-25) |